The Enterprise Value as of January 2026 (TTM) for Fractyl Health, Inc. Common Stock (GUTS) is 26.75M

According to Fractyl Health, Inc. Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 26.75M. This represents a change of -71.77% compared to the average of 94.79M of the last 4 quarters.

Fractyl Health, Inc. Common Stock (GUTS) Historical Enterprise Value (quarterly & annually)

How has GUTS Enterprise Value performed in the past?

The mean historical Enterprise Value of Fractyl Health, Inc. Common Stock over the last ten years is 679.75M. The current 26.75M Enterprise Value has changed 293.57% with respect to the historical average. Over the past ten years (40 quarters), GUTS's Enterprise Value was at its highest in in the December 2023 quarter at 951.95M. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.

Fractyl Health, Inc. Common Stock (GUTS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Fractyl Health, Inc. Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Fractyl Health, Inc. Common Stock (GUTS) Average Enterprise Value

How has GUTS Enterprise Value performed in the past?

The current Enterprise Value of Fractyl Health, Inc. Common Stock (GUTS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Fractyl Health, Inc. Common Stock (GUTS) Enterprise Value vs. Peers

How is GUTS’s Enterprise Value compared to its peers?

Fractyl Health, Inc. Common Stock’s Enterprise Value is less than Adverum Biotechnologies, Inc. (159.14M), less than ALX Oncology Holdings Inc. (66.03M), less than Precision BioSciences, Inc. (37.08M), less than Artiva Biotherapeutics, Inc. (88.04M), less than Sutro Biopharma, Inc. (78.84M), greater than Quince Therapeutics, Inc. (26.58M), less than Metagenomi, Inc. Common Stock (68.21M), less than Repare Therapeutics Inc. (41.75M), less than aTyr Pharma, Inc. (89.56M), less than Biomea Fusion, Inc. (30.44M),

Build a custom stock screener for Fractyl Health, Inc. Common Stock (GUTS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fractyl Health, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Fractyl Health, Inc. Common Stock (GUTS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Fractyl Health, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.